Drugs Control Administration authorities confiscated 'GRISOLAB-250' Griseofulvin Tablets 250 mg on wednesday in kothagudem due to overpricing. The product Griseofulvin Tablets 250 mg, sold under the brand name 'GRISOLAB-250', is subject to price regulation under the drugs (Prices regulation) Order, 2013, and its price shall be determined by the 'Ceiling Price' set by the National Pharmaceutical Pricing Authority (NPPA), government of India.

Laborate Pharmaceuticals india Ltd., 51, Industrial Area, Paonta Sahib, Himachal Pradesh, manufactures the product 'GRISOLAB-250' Griseofulvin Tablets 250 mg with B.No: GGST-007, Mfg Dt: 04/2023 and Exp Dt: 03/2026. Gpp Axalade, Salwan, haryana markets the medication with an MRP of Rs. 65 for 10 pills on the label, which violates the drugs (Prices Control) Order, 2013.

The real ceiling price set by the central government for "Griseofulvin Tablets 250 mg" is Rs 17.7 for ten pills.

As a result, DCA authorities stated that the Maximum Retail Price (MRP), which includes GST at 12%, should not exceed Rs. 19.83 for ten pills (MRP = Ceiling Price + GST).

The company overvalued the goods. A strip of ten pills has been priced more than Rs. 45.17 per ten tablets, which violates the drugs (Prices Control) Order, 2013.


Find out more: